PH12016500500A1 - A viral vaccine and methods of manufacture thereof - Google Patents
A viral vaccine and methods of manufacture thereofInfo
- Publication number
- PH12016500500A1 PH12016500500A1 PH12016500500A PH12016500500A PH12016500500A1 PH 12016500500 A1 PH12016500500 A1 PH 12016500500A1 PH 12016500500 A PH12016500500 A PH 12016500500A PH 12016500500 A PH12016500500 A PH 12016500500A PH 12016500500 A1 PH12016500500 A1 PH 12016500500A1
- Authority
- PH
- Philippines
- Prior art keywords
- manufacture
- methods
- virus
- viral vaccine
- culture
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title 1
- 229960004854 viral vaccine Drugs 0.000 title 1
- 241000700605 Viruses Species 0.000 abstract 2
- 238000009472 formulation Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 229960005486 vaccine Drugs 0.000 abstract 2
- 241000710842 Japanese encephalitis virus Species 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 238000004113 cell culture Methods 0.000 abstract 1
- 238000010961 commercial manufacture process Methods 0.000 abstract 1
- 238000002474 experimental method Methods 0.000 abstract 1
- 210000003501 vero cell Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24151—Methods of production or purification of viral material
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN4135CH2013 IN2013CH04135A (enrdf_load_html_response) | 2013-09-14 | 2014-09-08 | |
| PCT/IN2014/000585 WO2015059714A1 (en) | 2013-09-14 | 2014-09-08 | Emergency mode in a hybrid vehicle |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH12016500500A1 true PH12016500500A1 (en) | 2016-06-13 |
Family
ID=52997726
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH12016500500A PH12016500500A1 (en) | 2013-09-14 | 2016-03-14 | A viral vaccine and methods of manufacture thereof |
Country Status (6)
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106232800B (zh) | 2014-03-25 | 2020-07-03 | 泰尔茂比司特公司 | 介质的被动替代 |
| WO2017004592A1 (en) | 2015-07-02 | 2017-01-05 | Terumo Bct, Inc. | Cell growth with mechanical stimuli |
| CA3209607A1 (en) * | 2015-07-16 | 2017-01-19 | Bharat Biotech International Limited | Vaccine compositions |
| WO2017083286A1 (en) | 2015-11-09 | 2017-05-18 | University Of Notre Dame | Particle size purification method and devices |
| JP7034949B2 (ja) | 2016-05-25 | 2022-03-14 | テルモ ビーシーティー、インコーポレーテッド | 細胞の増殖 |
| US11685883B2 (en) | 2016-06-07 | 2023-06-27 | Terumo Bct, Inc. | Methods and systems for coating a cell growth surface |
| US11104874B2 (en) | 2016-06-07 | 2021-08-31 | Terumo Bct, Inc. | Coating a bioreactor |
| US11629332B2 (en) | 2017-03-31 | 2023-04-18 | Terumo Bct, Inc. | Cell expansion |
| MY193736A (en) | 2017-11-03 | 2022-10-27 | Takeda Vaccines Inc | Method for inactivating zika virus and for determining the completeness of inactivation |
| AU2018375789B2 (en) | 2017-11-30 | 2021-11-11 | Takeda Vaccines, Inc. | Method for inactivating Zika virus and related methods |
| EP3581646A1 (en) * | 2018-06-15 | 2019-12-18 | Themis Bioscience GmbH | Integrated manufacturing and chromatographic system for virus production |
| KR102655828B1 (ko) | 2018-08-16 | 2024-04-08 | 이엠디 밀리포어 코포레이션 | 폐쇄된 바이오프로세싱 장치 |
| CN111394321A (zh) * | 2020-03-30 | 2020-07-10 | 无锡加莱克色谱科技有限公司 | 病毒颗粒纯化用超大孔径层析介质及其应用方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE122009000037I2 (de) * | 1997-08-28 | 2011-06-16 | Cheil Jedang Corp | Ein an vero-zellen angepasstes abgeschwächtes japanisches enzephalitis virus und ein impfstoff gegen japanische enzephalitis |
| WO2010137036A2 (en) * | 2009-05-25 | 2010-12-02 | Panacea Biotec Ltd | Novel japanese encephalitis vaccine and method of manufacturing the same |
| CN102100910B (zh) * | 2009-12-21 | 2013-01-23 | 北京清大天一科技有限公司 | 一种生产病毒疫苗的方法 |
| CN103228293A (zh) * | 2010-11-30 | 2013-07-31 | 巴拉特生物技术国际有限公司 | 用于在哺乳动物中预防和治疗金迪普拉病毒感染的疫苗制剂 |
| US9580692B2 (en) * | 2012-02-29 | 2017-02-28 | Ge Healthcare Bioprocess R&D Ab | Method for endotoxin removal |
-
2014
- 2014-09-08 IN IN4135CH2013 patent/IN2013CH04135A/en unknown
- 2014-09-08 RU RU2016114285A patent/RU2706693C2/ru active
- 2014-09-08 AU AU2014338520A patent/AU2014338520B2/en active Active
- 2014-09-08 CN CN201480050520.1A patent/CN105744952A/zh active Pending
- 2014-09-08 WO PCT/IN2014/000585 patent/WO2015059714A1/en active Application Filing
-
2016
- 2016-03-14 PH PH12016500500A patent/PH12016500500A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2014338520A1 (en) | 2016-03-31 |
| AU2014338520B2 (en) | 2019-12-05 |
| CN105744952A (zh) | 2016-07-06 |
| IN2013CH04135A (enrdf_load_html_response) | 2015-08-14 |
| RU2706693C2 (ru) | 2019-11-20 |
| RU2016114285A3 (enrdf_load_html_response) | 2018-07-16 |
| RU2016114285A (ru) | 2017-10-19 |
| WO2015059714A8 (en) | 2015-06-18 |
| WO2015059714A1 (en) | 2015-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12016500500A1 (en) | A viral vaccine and methods of manufacture thereof | |
| PH12018501602A1 (en) | Subunit immersion vaccines for fish | |
| PH12018500855A1 (en) | Herpes simplex virus vaccine | |
| PH12015501526B1 (en) | Stabilized human immunodeficiency virus (hiv) envelope (env) trimer vaccines and methods of using same | |
| MX2022006603A (es) | Vacuna contra el virus de la influenza de amplio espectro. | |
| MX2018010483A (es) | Inmunogenos para vacunacion contra vih. | |
| PH12013502442A1 (en) | Inactivated dengue virus vaccine | |
| MX2017004542A (es) | Inmunomoduladores. | |
| MX2017007196A (es) | Fibroblastos de embrion de pollo inmortalizados. | |
| WO2015052543A3 (en) | Malaria vaccination | |
| MY191539A (en) | Streptococcal vaccine | |
| NZ702146A (en) | Peptides derived from viral proteins for use as immunogens and dosage reactants | |
| EP3939604A3 (en) | Influenza hemagglutinin protein vaccines | |
| PL3504225T3 (pl) | Nowe antygeny białkowe otoczki ludzkiego wirusa niedoboru odporności eksprymowane przez ssaki | |
| MA37749B1 (fr) | Vaccins contre les virus réassortis de la fièvre catarrhale et de la peste équine | |
| MX2019007252A (es) | Metodos y composiciones para vacunas del virus del dengue. | |
| MX2018014955A (es) | Vacunas atenuadas vivas del virus de la influenza equina. | |
| MX2019007924A (es) | Vacunas contra la influenza. | |
| HK40016413A (en) | Respiratory virus nucleic acid vaccines | |
| WO2014174532A3 (en) | An improved process for the preparation of emtricitabine | |
| UA59897U (ru) | Способ изготовления вакцины против бешенства животных "рабизин" |